The Patent Finder

Regulon, Inc.

Also on record
Records under this name other than patents Regulon, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 5 of 5 · Back to Regulon, Inc.

PatentTitleStatus Expires Confidence
US 9,278,067Encapsulation of plasmid DNA (lipogenes™) and therapeutic agents with nuclear localization signal/fusogenic peptide conjugates into targeted liposome complexes
Lapsed on the fee record
Ended Mar 8, 2020 · From the USPTO record
Lapsed on the fee recordEnded Mar 8, 2020From the USPTO record
US 6,511,676Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes
Term ended
Term ended Nov 5, 2019 · From the USPTO record
Term endedTerm ended Nov 5, 2019From the USPTO record
US 6,030,956Combination gene therapy for human cancers
Term ended
Term ended Oct 23, 2017 · From the USPTO record
Term endedTerm ended Oct 23, 2017From the USPTO record
US 7,393,478Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes
Lapsed on the fee record
Ended Jul 1, 2016 · From the USPTO record
Lapsed on the fee recordEnded Jul 1, 2016From the USPTO record
US 5,894,060Cloning method for trapping human origins of replication
Term ended
Term ended no later than Apr 13, 2019 · Low confidence
Term endedTerm ended no later than Apr 13, 2019Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited